ReviewCurrent gastroenterology reports2021

Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).

Lindsey Sattler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.